AU2002220419A1 - Prolamin-based sustained-release compositions and delayed-onset compositions - Google Patents
Prolamin-based sustained-release compositions and delayed-onset compositionsInfo
- Publication number
- AU2002220419A1 AU2002220419A1 AU2002220419A AU2041902A AU2002220419A1 AU 2002220419 A1 AU2002220419 A1 AU 2002220419A1 AU 2002220419 A AU2002220419 A AU 2002220419A AU 2041902 A AU2041902 A AU 2041902A AU 2002220419 A1 AU2002220419 A1 AU 2002220419A1
- Authority
- AU
- Australia
- Prior art keywords
- compositions
- prolamin
- delayed
- onset
- based sustained
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2063—Proteins, e.g. gelatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
- A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/2873—Proteins, e.g. gelatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2893—Tablet coating processes
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/728,840 | 2000-12-01 | ||
US09/728,840 US20020106408A1 (en) | 2000-12-01 | 2000-12-01 | Prolamin-based sustained-release compositions and delayed-onset compositions |
PCT/CA2001/001716 WO2002043706A2 (en) | 2000-12-01 | 2001-11-30 | Prolamin-based sustained-release compositions and delayed-onset compositions |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2002220419A1 true AU2002220419A1 (en) | 2002-06-11 |
Family
ID=24928479
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2002220419A Abandoned AU2002220419A1 (en) | 2000-12-01 | 2001-11-30 | Prolamin-based sustained-release compositions and delayed-onset compositions |
Country Status (6)
Country | Link |
---|---|
US (1) | US20020106408A1 (en) |
EP (1) | EP1343482A2 (en) |
AR (1) | AR031772A1 (en) |
AU (1) | AU2002220419A1 (en) |
CA (1) | CA2433668A1 (en) |
WO (1) | WO2002043706A2 (en) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20060018962A1 (en) * | 2002-03-22 | 2006-01-26 | Reza Eivaskhani | Sustained release formulation of tramadol |
CA2498798A1 (en) * | 2002-09-20 | 2004-04-01 | Alpharma, Inc. | Sustained-release opioid formulations and methods of use |
TWI319713B (en) * | 2002-10-25 | 2010-01-21 | Sustained-release tramadol formulations with 24-hour efficacy | |
US8487002B2 (en) * | 2002-10-25 | 2013-07-16 | Paladin Labs Inc. | Controlled-release compositions |
US20060172006A1 (en) * | 2003-10-10 | 2006-08-03 | Vincent Lenaerts | Sustained-release tramadol formulations with 24-hour clinical efficacy |
CA2600736A1 (en) * | 2005-03-16 | 2006-09-21 | Dr. Reddy's Laboratories Ltd. | Delivery system for multiple drugs |
BRPI0615860B8 (en) | 2005-09-09 | 2021-05-25 | Labopharm Barbados Ltd | solid monolithic extended release pharmaceutical composition |
US8148560B2 (en) * | 2005-09-23 | 2012-04-03 | Teva Women's Health, Inc. | Vaginal tablets comprising misoprostol and methods of making and using the same |
AU2007205893A1 (en) * | 2006-01-19 | 2007-07-26 | The Curators Of The University Of Missouri | Pharmaceutical composition comprising a protein pump inhibitor and protein component |
KR20100069685A (en) * | 2007-10-16 | 2010-06-24 | 라보팜 인코포레이트 | Bilayer composition for the sustained release of acetaminophen and tramadol |
ES2419204T3 (en) | 2008-05-27 | 2013-08-19 | The University Of Melbourne | Methods to treat mammals with eustachian tube dysfunctions |
ES2536736T3 (en) * | 2008-09-04 | 2015-05-28 | Farnam Companies, Inc. | Chewable sustained release formulations |
CN101843577A (en) * | 2010-04-08 | 2010-09-29 | 安徽中医学院 | Coating implant using zein as skeleton material and preparation method |
EP2642872A1 (en) * | 2010-11-26 | 2013-10-02 | DSM IP Assets B.V. | Protective hydrocolloid for active ingredients |
CN102247368B (en) * | 2011-05-19 | 2013-05-29 | 安徽永生堂药业有限责任公司 | Compound acrivastine sustained release tablets, and preparation method thereof |
WO2016046817A1 (en) * | 2014-09-24 | 2016-03-31 | Vital Beverages Global Inc. | Compositions and methods for selective gi tract delivery |
DE102015014581A1 (en) * | 2015-11-12 | 2017-05-18 | Nele Schmidt | Prolamine-containing gels, process for their preparation and their use |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB935672A (en) * | 1960-07-19 | 1963-09-04 | Sterling Drug Inc | Sustained release tablet |
US3477864A (en) * | 1965-05-07 | 1969-11-11 | Sumitomo Chemical Co | Process for coating pharmaceutical preparations with a hydroxy propyl methyl cellulose-sealing agent moisture-preventing film |
US3558768A (en) * | 1969-12-19 | 1971-01-26 | Sterling Drug Inc | Sustained release pharmaceutical compositions |
US4007258A (en) * | 1973-09-10 | 1977-02-08 | Union Corporation | Sustained release pesticidal composition |
US4704284A (en) * | 1982-08-12 | 1987-11-03 | Pfizer Inc. | Long-acting matrix tablet formulations |
WO1991006227A1 (en) * | 1989-11-06 | 1991-05-16 | Opta Food Ingredients, Inc. | Protein-based edible coatings |
US5160742A (en) * | 1991-12-31 | 1992-11-03 | Abbott Laboratories | System for delivering an active substance for sustained release |
US5324351A (en) * | 1992-08-13 | 1994-06-28 | Euroceltique | Aqueous dispersions of zein and preparation thereof |
DE10016356B4 (en) * | 2000-04-03 | 2007-06-21 | Beisel, Günther | Improved retarding agent and method for its production |
-
2000
- 2000-12-01 US US09/728,840 patent/US20020106408A1/en not_active Abandoned
-
2001
- 2001-11-30 AU AU2002220419A patent/AU2002220419A1/en not_active Abandoned
- 2001-11-30 EP EP01998332A patent/EP1343482A2/en not_active Withdrawn
- 2001-11-30 CA CA002433668A patent/CA2433668A1/en not_active Abandoned
- 2001-11-30 WO PCT/CA2001/001716 patent/WO2002043706A2/en not_active Application Discontinuation
- 2001-12-03 AR ARP010105598A patent/AR031772A1/en unknown
Also Published As
Publication number | Publication date |
---|---|
WO2002043706A9 (en) | 2002-12-19 |
EP1343482A2 (en) | 2003-09-17 |
AR031772A1 (en) | 2003-10-01 |
US20020106408A1 (en) | 2002-08-08 |
CA2433668A1 (en) | 2002-06-06 |
WO2002043706A2 (en) | 2002-06-06 |
WO2002043706A3 (en) | 2003-03-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2001294814A1 (en) | Pumpcn compositions and uses thereof | |
AU2002357119A1 (en) | Mitocidal compositions and methods | |
AU2002235128A1 (en) | Expression miniarrays and uses thereof | |
AU2778801A (en) | Antisense compositions and methods | |
AU2001265008A1 (en) | Caspase inhibitors and uses thereof | |
AUPQ419099A0 (en) | Novel compositions and methods | |
AU2001250875A1 (en) | Anti-microbial and immunostimulating composition | |
AU2001280604A1 (en) | Compositions comprising icariside i and anhydroicaritin and methods for making the same | |
AU2001280599A1 (en) | Compounds and methods | |
AU2001253418A1 (en) | Compounds and methods | |
AU2002220419A1 (en) | Prolamin-based sustained-release compositions and delayed-onset compositions | |
AU2002211717A1 (en) | Stresscopins and their uses | |
AU2001272011A1 (en) | Siderophores-producing bifidobacteria thereby and uses thereof | |
AU2001243394A1 (en) | Compounds and methods | |
AU2001292936A1 (en) | Octahydro-indolizines and quinolizines and hexahydro-pyrrolizines | |
AU2002357748A1 (en) | Osteopontin-related compositions and methods | |
AU2001229439A1 (en) | Bioconjugates and uses thereof | |
AU2001295185A1 (en) | Multiplexing-interleaving and demultiplexing-deinterleaving | |
AU2001233932A1 (en) | Method and composition | |
AUPQ872300A0 (en) | Compounds and methods | |
GB0027391D0 (en) | Films and compositions | |
AU1152601A (en) | Compositions and their use | |
AU2001278951A1 (en) | Compounds and methods | |
AU2001261317A1 (en) | Immunostimulant compositions and associated methods | |
AU2002239775A1 (en) | Chemical-library composition and method |